NovoCure Ltd

NVCR

NVCR has 5 disclosed filings on Paydirt over the trailing twelve months from 4 corporate insiders: 0 purchases and 5 sales. Filers took a median of 2 days from execution to disclosure, and the most recent trade was executed Jun 4 and filed Jun 5. The most active filer was Frank X Leonard with 5 filings.

Add to watchlist

Filings, ttm

0 buys · 5 sells

Traders, ttm

4 insiders

Volume, ttmiDollar value disclosed in the window

$2.4M

estimated for Congress, as filed for insiders

Median delay

execution to disclosure

Last traded

Jun 4

Filed Jun 5

ADViAverage daily dollar volume

–

not on file

Share price · 12M

$16.01 (+22.3%)

Adjusted for splits and dividends.

Volume by month

Buys $1.1M Sells $3.7M

Estimated for Congress, as filed for insiders · by filing month · past 24 months

Who filed

FL Frank X Leonard EVP, Pres., Novocure Oncology 5 filings AC Ashley Cordova Chief Executive Officer 3 filings CB Christoph Brackmann Chief Financial Officer 1 filing WD William F Doyle Executive Chairman 1 filing MP Mukund Paravasthu Chief Operating Officer 1 filing UW Uri Weinberg Chf Medical and Innovation Ofr 1 filing

Recent filings

Frank X LeonardSALE Chief Executive Officer $615K
34,273 sh × $17.93
Exec Jun 4
Filed Jun 5 · 5:30 PM ET William F DoyleSALE Executive Chairman $933K
71,887 sh across 2 lots
Exec Mar 3
Filed Mar 5 · 5:30 PM ET Mukund ParavasthuSALE Chief Operating Officer $595K
43,246 sh × $13.77
Exec Mar 5
Filed Mar 5 · 5:30 PM ET Frank X LeonardSALE Chief Executive Officer $133K
9,734 sh × $13.66
Exec Feb 27
Filed Mar 3 · 5:30 PM ET Uri WeinbergSALE Chf Medical and Innovation Ofr $103K
7,461 sh × $13.84
Exec Feb 27
Filed Mar 3 · 5:30 PM ET Ashley CordovaPURCHASE Chief Executive Officer $997K
81,550 sh × $12.22
Exec Sep 5 2025
Filed Sep 8 2025 · 7:10 AM ET Christoph BrackmannPURCHASE Chief Financial Officer $116K
10,000 sh × $11.63
Exec Jul 29 2025
Filed Jul 30 2025 · 4:33 PM ET Frank X LeonardSALE EVP, Pres., Novocure Oncology $493K
28,317 sh across 2 lots
Exec Jun 2 2025
Filed Jun 4 2025 · 5:30 PM ET Ashley CordovaSALE Chief Executive Officer $186K
9,345 sh × $19.92
Exec Feb 27 2025
Filed Mar 3 2025 · 5:30 PM ET Frank X LeonardSALE EVP, Pres., Novocure Oncology $205K
10,277 sh × $19.92
Exec Feb 27 2025
Filed Mar 3 2025 · 5:30 PM ET Frank X LeonardSALE EVP, Pres., Novocure Oncology $205K
10,277 sh × $19.92
Exec Feb 27 2025
Filed Mar 3 2025 · 5:30 PM ET Ashley CordovaSALE Chief Executive Officer $186K
9,345 sh × $19.92
Exec Feb 27 2025
Filed Mar 3 2025 · 5:30 PM ET